Supernus Pharma (SUPN)
44.38
+0.80 (1.84%)
Upcoming Events
Latest Headlines
Form 8-K SUPERNUS PHARMACEUTICALS For: Jun 18
June 18, 2026 4:56 PM - SEC Filing
Supernus names MERGE as agency of record for its CNS portfolio
June 17, 2026 10:15 AM - StreetInsider
Supernus Expands Partnership With MERGE as AI-Powered Agency of Record
June 17, 2026 10:15 AM - StreetInsider
Supernus Pharmaceuticals to Participate in June Investor Conferences
May 27, 2026 4:30 PM - Globe NewsWire
Form 8-K SUPERNUS PHARMACEUTICALS For: May 17
May 20, 2026 4:37 PM - SEC Filing
Supernus Pharmaceuticals to Participate in the Bank of America 2026 Health Care Conference
May 6, 2026 5:00 PM - Globe NewsWire
Form 10-Q SUPERNUS PHARMACEUTICALS For: Mar 31
May 5, 2026 4:16 PM - SEC Filing
Form 8-K SUPERNUS PHARMACEUTICALS For: May 05
May 5, 2026 4:10 PM - SEC Filing
Supernus Announces First Quarter 2026 Financial Results
May 5, 2026 4:05 PM - StreetInsider
Form ARS SUPERNUS PHARMACEUTICALS For: Dec 31
April 30, 2026 5:06 PM - SEC Filing
Form DEFA14A SUPERNUS PHARMACEUTICALS
April 30, 2026 5:05 PM - SEC Filing
Form DEF 14A SUPERNUS PHARMACEUTICALS For: Jun 18
April 30, 2026 5:01 PM - SEC Filing
Form SCHEDULE 13G SUPERNUS PHARMACEUTICALS Filed by: VANGUARD CAPITAL MANAGEMENT LLC
April 30, 2026 2:06 PM - SEC Filing
Form SCHEDULE 13G SUPERNUS PHARMACEUTICALS Filed by: VANGUARD PORTFOLIO MANAGEMENT LLC
April 29, 2026 3:21 PM - SEC Filing
Supernus Pharmaceuticals (SUPN) PT Lowered to $62 at BofA Securities
April 27, 2026 5:21 AM - StreetInsider
Form 8-K SUPERNUS PHARMACEUTICALS For: Apr 22
April 22, 2026 4:33 PM - SEC Filing
Supernus Pharmaceuticals to Announce First Quarter 2026 Financial Results and Host Conference Call on May 5, 2026
April 22, 2026 4:15 PM - StreetInsider
Alpha Cognition appoints Bethany Sensenig to board of directors
April 20, 2026 5:00 PM - StreetInsider
Alpha Cognition Strengthens Its Board of Directors with Appointment of Bethany Sensenig
April 20, 2026 5:00 PM - BizWire
Form 8-K SUPERNUS PHARMACEUTICALS For: Apr 01
April 7, 2026 5:26 PM - SEC Filing
Form SCHEDULE 13G/A SUPERNUS PHARMACEUTICALS Filed by: VANGUARD GROUP INC
March 27, 2026 1:19 PM - SEC Filing
Jefferies stays Buy on Supernus Pharmaceuticals (SUPN) as weekly scripts near 'historical levels'
March 23, 2026 3:11 PM - StreetInsider
Full Article List
